ArticleCase reports in nephrology2025
SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series.
Fatima Ayub et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.